Skip to content
About CombiGene
Projects
The pain program COZY
The epilepsy project CG01
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Articles of association (SE)
Company description (SE)
Organization
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
About CombiGene
Projects
The pain program COZY
The epilepsy project CG01
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Articles of association (SE)
Company description (SE)
Organization
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
SV
CombiGene establishes UK subsidiary to secure close and effective collaboration with Cell and Gene Therapy Catapult
January 31, 2018
Read more >>
Share
News
January 9, 2025
Stockslätten AB acquires all shares from Strategic Partners A/S
January 9, 2025
Clarification regarding the management’s role during the restructuring period
January 9, 2025
CombiGene initiates restructuring as part of strategic review to maximize shareholder value
December 17, 2024
CombiGene AB (publ): Nominating committee
December 10, 2024
Bulletin from the Extraordinary General Meeting of CombiGene AB (publ)
December 2, 2024
CombiGene conducts Extraordinary General Meeting
November 14, 2024
Shareholders’ proposal for election of Board of Directors
November 8, 2024
Interim report January – September 2024 for CombiGene AB (publ)
Load more
We use cookies to ensure that we give you the best experience on our website. If you continue to use this website, we will assume that you accept it.
Ok
Privacy policy
